Biophytis SA (FR:ALBPS) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Biophytis SA, a biotech firm focusing on age-related diseases, announced the adoption of all its proposed resolutions at the Combined General Meeting on June 24, 2024. Shareholder engagement allowed the meeting to proceed with a quorum of 34%. Key resolutions included the approval of the 2023 financial statements and the re-election of three directors for another three-year term.
For further insights into FR:ALBPS stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money